Palivizumab prophylaxis for respiratory syncytial virus (RSV) in infants with cystic fibrosis (CF) and respiratory illness hospitalizations

被引：2
|
作者：
Bjornson, Candice [1 ]
Chan, Parco [2 ,3 ]
Li, Abby [2 ,3 ]
Paes, Bosco [4 ]
Lanctot, Krista [2 ,3 ]
Mitchell, Ian [1 ]
机构：
[1] Univ Calgary, Pediat, Calgary, AB, Canada
[2] Univ Toronto, Pharmacol & Toxicol, Toronto, ON, Canada
[3] Sunnybrook Res Inst, MOREr Res Grp, Toronto, ON, Canada
[4] McMaster Univ, Pediat, Hamilton, ON, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷
关键词：
Infections; Cystic fibrosis; Infants;
D O I：
10.1183/13993003.congress-2015.PA3625
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA3625
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?
    Candice Bjornson
    Parco Chan
    Abby Li
    Bosco Paes
    Krista L. Lanctôt
    Ian Mitchell
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 1113 - 1118
  • [2] Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?
    Bjornson, Candice
    Chan, Parco
    Li, Abby
    Paes, Bosco
    Lanctot, Krista L.
    Mitchell, Ian
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (06) : 1113 - 1118
  • [3] Effectiveness of Palivizumab in Respiratory Syncytial Virus Prophylaxis in Children with Cystic Fibrosis
    Winterstein, Almut G.
    Eworuke, Efe
    Xu, Dandan
    Schuler, Pamela
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 148 - 148
  • [4] Respiratory illness and respiratory syncytial virus hospitalization in infants with a tracheostomy following prophylaxis with palivizumab
    Bosco Paes
    Mahwesh Saleem
    Doyoung Kim
    Krista L. Lanctôt
    Ian Mitchell
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 1561 - 1568
  • [5] Respiratory illness and respiratory syncytial virus hospitalization in infants with a tracheostomy following prophylaxis with palivizumab
    Paes, Bosco
    Saleem, Mahwesh
    Kim, Doyoung
    Lanctot, Krista L.
    Mitchell, Ian
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (08) : 1561 - 1568
  • [6] Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants
    Pedraz, C
    Carbonell-Estrany, X
    Figueras-Aloy, J
    Quero, J
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (09) : 823 - 827
  • [7] Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
    Mejias, Asuncion
    Ramilo, Octavio
    [J]. BIOLOGICS-TARGETS & THERAPY, 2008, 2 (03): : 433 - 439
  • [8] Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis
    Robinson, Karen A.
    Odelola, Olaide A.
    Saldanha, Ian J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (07):
  • [9] Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis
    Robinson, Karen A.
    Odelola, Olaide A.
    Saldanha, Ian
    Mckoy, Naomi
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (02):
  • [10] Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis
    Robinson, Karen A.
    Odelola, Olaide A.
    Saldanha, Ian J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (05):
12345